Acquisitions - Officinae Bio (Details) - Officinae Bio - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Feb. 21, 2025 |
Sep. 30, 2025 |
|
| Business Combination [Line Items] | ||
| Consideration transferred | $ 15.1 | |
| Potential consideration payments | 35.0 | |
| Milestone Consideration | ||
| Business Combination [Line Items] | ||
| Potential consideration payments | 5.0 | |
| Payments of acquisition related contingent consideration and consideration holdback | $ 5.0 | |
| Earnout Considerations | ||
| Business Combination [Line Items] | ||
| Potential consideration payments | $ 30.0 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|